Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Elevai Labs, Inc. - Common Stock (NQ: ELAB ) 0.4425 -0.0019 (-0.43%) Streaming Delayed Price Updated: 3:59 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Elevai Labs, Inc. - Common Stock < Previous 1 2 Next > Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket July 25, 2024 Via Benzinga Top 4 Risk Off Stocks You'll Regret Missing In July July 16, 2024 Via Benzinga Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line June 28, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024 June 26, 2024 From Elevai Labs Inc. Via GlobeNewswire ELAB Stock Earnings: Elevai Labs Reported Results for Q1 2024 May 15, 2024 Elevai Labs just reported results for the first quarter of 2024. Via InvestorPlace ELAB Stock Earnings: Elevai Labs Reported Results for Q4 2023 April 02, 2024 Elevai Labs just reported results for the fourth quarter of 2023. Via InvestorPlace Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs June 14, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm May 29, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference May 22, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries May 17, 2024 Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries Via News Direct Elevai Labs Inc. Reports First Quarter 2024 Financial Results May 15, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity May 02, 2024 From Elevai Labs Inc. Via GlobeNewswire 12 Consumer Staples Stocks Moving In Wednesday's After-Market Session May 01, 2024 Via Benzinga Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare May 01, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments May 01, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments April 29, 2024 From Elevai Labs Inc. Via GlobeNewswire ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months April 22, 2024 From Elevai Labs Inc. Via GlobeNewswire 12 Consumer Staples Stocks Moving In Tuesday's After-Market Session April 09, 2024 Via Benzinga Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results March 29, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market March 18, 2024 ELEVAI Physician-Dispensed Skincare Now Available Direct to Consumers From Elevai Labs Inc. Via GlobeNewswire Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket February 22, 2024 Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday February 22, 2024 Pre-market stock movers are a hot topic on Thursday and we're starting the day with a breakdown of all the latest news this morning! Via InvestorPlace Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket February 06, 2024 Shares of Palantir Technologies Inc. (NYSE: PLTR) rose sharply during today’s pre-market trading after the company reported better-than-expected fourth-quarter sales results and issued guidance. Via Benzinga Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 01, 2024 Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. Via Benzinga Why Is Revelation Biosciences (REVB) Stock Down 62% Today? February 01, 2024 Revelation Biosciences stock is falling on Thursday after the company announced the price of a public offering for REVB shares. Via InvestorPlace Why Is Kiora Pharmaceuticals (KPRX) Stock Up 39% Today? February 01, 2024 Kiora Pharmaceuticals stock is rising higher on Thursday as KPRX investors react to a new $45 million private placement. Via InvestorPlace Why Is Elevai Labs (ELAB) Stock Up 57% Today? February 01, 2024 Elevai Labs stock is on the rise Thursday alongside heavy trading of ELAB shares despite a lack of news from the skincare company. Via InvestorPlace Why Nextracker Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket February 01, 2024 Shares of Nextracker Inc. (NASDAQ: NXT) rose sharply during today’s pre-market trading after the company reported better-than-expected thi Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday February 01, 2024 It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning! Via InvestorPlace ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office January 24, 2024 Utility Patent Covers the formulation for ELEVAI’s flagship exosome-based skin care products From Elevai Labs Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.